Literature DB >> 2342366

Communication skills training, communication skills training with family and cognitive behavioral mood management training for alcoholics.

P M Monti1, D B Abrams, J A Binkoff, W R Zwick, M R Liepman, T D Nirenberg, D J Rohsenow.   

Abstract

To evaluate three promising social learning approaches to the treatment of alcoholism, 69 male alcoholics in standard inpatient treatment participated in either a communication skills training group (CST), a communication skills training group with family participation (CSTF) or a cognitive behavioral mood management training group (CBMMT). Alcoholics who received CST or CSTF drank significantly less alcohol per drinking day during 6-month follow-up than those in CBMMT. The groups did not differ in abstinence rates or latency to relapse. All groups improved in skill and anxiety on the extensive battery of process measures, including role-play tests of general and alcohol-specific coping skills, but those in CST improved most in skill in alcohol-specific high-risk role plays and in ability to relax after the role plays. Alcoholics' skill, response latency, anxiety and urge to drink during alcohol-specific role plays were highly correlated with treatment outcome, demonstrating the importance of including comprehensive process measures in treatment outcome research. Implications for patient-treatment matching and future research are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2342366     DOI: 10.15288/jsa.1990.51.263

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  28 in total

Review 1.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

2.  A daily process examination of the bidirectional relationship between craving and alcohol consumption as measured via interactive voice response.

Authors:  Tera L Fazzino; Valerie S Harder; Gail L Rose; John E Helzer
Journal:  Alcohol Clin Exp Res       Date:  2013-07-24       Impact factor: 3.455

Review 3.  [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].

Authors:  J Wrase; S M Grüsser; A Heinz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

4.  Self-efficacy for cocaine abstinence: pretreatment correlates and relationship to outcomes.

Authors:  Sara L Dolan; Rosemarie A Martin; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2007-12-07       Impact factor: 3.913

5.  Individual versus significant-other-enhanced brief motivational intervention for alcohol in emergency care.

Authors:  Peter M Monti; Suzanne M Colby; Nadine R Mastroleo; Nancy P Barnett; Chad J Gwaltney; Timothy R Apodaca; Damaris J Rohsenow; Molly Magill; Aruna Gogineni; Michael J Mello; Walter L Biffl; William G Cioffi
Journal:  J Consult Clin Psychol       Date:  2014-08-11

6.  Bringing alcohol treatment to driving under the influence programs: Perceptions from first-time offenders.

Authors:  Karen Chan Osilla; Magdalena Kulesza; Jeanne Miranda
Journal:  Alcohol Treat Q       Date:  2017-03-20

Review 7.  Identifying the neural circuitry of alcohol craving and relapse vulnerability.

Authors:  Andreas Heinz; Anne Beck; Sabine M Grüsser; Anthony A Grace; Jana Wrase
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

8.  Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.

Authors:  Clara M Bradizza; Stephen A Maisto; Paula C Vincent; Paul R Stasiewicz; Gerard J Connors; Nicole D Mercer
Journal:  J Consult Clin Psychol       Date:  2009-12

9.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

10.  The key relative's impact on treatment and course of alcoholism.

Authors:  M M Fichter; U Frick
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.